The progression of inorganic nanoparticles and natural products for inflammatory bowel disease

被引:23
|
作者
Li, Qingrong [1 ]
Lin, Liting [2 ]
Zhang, Cong [3 ]
Zhang, Hengguo [4 ]
Ma, Yan [3 ]
Qian, Haisheng [3 ]
Chen, Xu-Lin [5 ]
Wang, Xianwen [3 ]
机构
[1] Anhui Med Univ, Sch Basic Med Sci, Dept Pharmacol, Hefei 230032, Peoples R China
[2] Anhui Med Univ, Anhui Prov Inst Translat Med, Res & Engn Ctr Biomed Mat, Sch Biomed Engn, Hefei 230032, Peoples R China
[3] Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Gastroenterol, Div Life Sci & Med, Hefei 230026, Anhui, Peoples R China
[4] Anhui Med Univ, Coll & Hosp Stomatol, Key Lab Oral Dis Res Anhui Prov, Hefei 230032, Peoples R China
[5] Anhui Med Univ, Affiliated Hosp 1, Dept Burns, Hefei 230022, Peoples R China
关键词
Inflammatory bowel disease; Inorganic nanoparticles; Natural product nanomaterials; ROS/RNS; M1; macrophages; TNBS-INDUCED COLITIS; NITRIC-OXIDE; ULCERATIVE-COLITIS; MACROPHAGE POLARIZATION; COLORECTAL-CANCER; SIGNALING PATHWAY; REACTIVE OXYGEN; SELENIUM; CURCUMIN; BAICALIN;
D O I
10.1186/s12951-023-02246-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
There is a growing body of evidence indicating a close association between inflammatory bowel disease (IBD) and disrupted intestinal homeostasis. Excessive production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), along with an increase in M1 proinflammatory macrophage infiltration during the activation of intestinal inflammation, plays a pivotal role in disrupting intestinal homeostasis in IBD. The overabundance of ROS/RNS can cause intestinal tissue damage and the disruption of crucial gut proteins, which ultimately compromises the integrity of the intestinal barrier. The proliferation of M1 macrophages contributes to an exaggerated immune response, further compromising the intestinal immune barrier. Currently, intestinal nanomaterials have gained widespread attention in the context of IBD due to their notable characteristics, including the ability to specifically target regions of interest, clear excess ROS/RNS, and mimic biological enzymes. In this review, we initially elucidated the gut microenvironment in IBD. Subsequently, we delineate therapeutic strategies involving two distinct types of nanomedicine, namely inorganic nanoparticles and natural product nanomaterials. Finally, we present a comprehensive overview of the promising prospects associated with the application of nanomedicine in future clinical settings for the treatment of IBD (graphic abstract).Graphical AbstractDifferent classes of nanomedicine are used to treat IBD. This review primarily elucidates the current etiology of inflammatory bowel disease and explores two prominent nanomaterial-based therapeutic approaches. First, it aims to eliminate excessive reactive oxygen species and reactive nitrogen species. Second, they focus on modulating the polarization of inflammatory macrophages and reducing the proportion of pro-inflammatory macrophages. Additionally, this article delves into the treatment of inflammatory bowel disease using inorganic metal nanomaterials and natural product nanomaterials
引用
收藏
页数:28
相关论文
共 50 条
  • [31] The Potential of Natural Oils to Improve Inflammatory Bowel Disease
    Zhou, Yaxi
    Wang, Diandian
    Duan, Hao
    Zhou, Shiqi
    Guo, Jinhong
    Yan, Wenjie
    NUTRIENTS, 2023, 15 (11)
  • [32] Emerging Natural Therapies for the Treatment of Inflammatory Bowel Disease
    Joshi, Monika
    Pandey, Manju
    Shankar, Ravi
    Ved, Akash
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024,
  • [33] Epidemiology and natural history of chronic inflammatory bowel disease
    Lerebours, E
    Savoye, G
    Guedon, C
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 27 : S76 - S80
  • [34] Natural Products: A Dependable Source of Therapeutic Alternatives for Inflammatory Bowel Disease through Regulation of Tight Junctions
    Peng, Jing
    Li, Hao
    Olaolu, Oladejo Ayodele
    Ibrahim, Saber
    Ibrahim, Sally
    Wang, Shengyi
    MOLECULES, 2023, 28 (17):
  • [35] Crucial steps in the natural history of inflammatory bowel disease
    Latella, Giovanni
    Papi, Claudio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (29) : 3790 - 3799
  • [36] Crucial steps in the natural history of inflammatory bowel disease
    Giovanni Latella
    Claudio Papi
    World Journal of Gastroenterology, 2012, 18 (29) : 3790 - 3799
  • [37] Immune mechanisms and natural history of inflammatory bowel disease
    Katsanos, K. H.
    Tsianos, E. V.
    ANNALS OF GASTROENTEROLOGY, 2006, 19 (02): : 184 - 188
  • [38] The placebo response and the "natural history" of inflammatory bowel disease
    Janowitz, HD
    Bodian, C
    INFLAMMATORY BOWEL DISEASES, 2001, 7 (01) : 64 - 66
  • [39] Serum bacterial toxins are related to the progression of inflammatory bowel disease
    Qiu, Huajing
    Sun, Xiaomin
    Sun, Mingming
    He, Chong
    Li, Zhong
    Liu, Zhanju
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (07) : 826 - 833